Skip to main content
Top
Published in:

Open Access 27-06-2024 | Arteriovenous Fistula | Case Report

A massive pulmonary arteriovenous fistula complicated with coronary atherosclerotic heart disease treated by interventional therapy: a case report

Authors: Jingwen Guo, Hongyong Wang, Mingming Zhang

Published in: Journal of Cardiothoracic Surgery | Issue 1/2024

Login to get access

Abstract

Background

Pulmonary arteriovenous fistula (PAVF) is a rare disease, and its symptoms lack specificity. For patients with coronary heart disease(CHD), hypertension and other common cardiovascular diseases, PAVF is easy to be ignored. We presented a case of massive PAVF complicated with coronary atherosclerotic heart disease by interventional treatment to improve the understanding of this complex disease.

Case presentation

A 77-year-old female patient was admitted to the hospital due to chest tightness and shortness of breath following activities, which was diagnosed with CHD and hypoxemia in other hospitals. Coronary angiography showed that the patient had severe stenosis of coronary artery while pulmonary vascular DSA showing the patient had PAVF. After interventional therapy of both coronary artery and PAVF, the patient's symptoms were significantly improved.

Conclusion

We presented a case of massive PAVF complicated with CHD by interventional treatment. For patients with unexplained hypoxemia and symptoms similar with CHD, the possibility of PAVF often leads to oversight, and various auxiliary examinations should be improved to avoid missed diagnosis. And intervention treatment should be carried out to improve the prognosis of patients as much as possible.
Literature
1.
go back to reference Lacombe P, Lacout A, Marcy PY, et al. Diagnosis and treatment of pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: An overview. DiagnIntervImaging. 2013;94:835–48. Lacombe P, Lacout A, Marcy PY, et al. Diagnosis and treatment of pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: An overview. DiagnIntervImaging. 2013;94:835–48.
2.
go back to reference Shovlin CL, Condliffe R, Donaldson JW, et al. British thoracic society clinical statement onpulmonary arteriovenous malformations. Thorax. 2017;72:1154–63.CrossRefPubMed Shovlin CL, Condliffe R, Donaldson JW, et al. British thoracic society clinical statement onpulmonary arteriovenous malformations. Thorax. 2017;72:1154–63.CrossRefPubMed
3.
go back to reference Hu SS, Gao RL, Liu LS, et al. Summary of “the 2018 report on cardiovascular diseases in China.” Chin Circ J. 2019;34:209–20. Hu SS, Gao RL, Liu LS, et al. Summary of “the 2018 report on cardiovascular diseases in China.” Chin Circ J. 2019;34:209–20.
4.
go back to reference Yap CW, Wee BBK, Yee SY, et al. The Role of Interventional Radiology in the Diagnosis and Treatment of Pulmonary Arteriovenous Malformations. J Clin Med. 2022;11(21):6282.CrossRefPubMedPubMedCentral Yap CW, Wee BBK, Yee SY, et al. The Role of Interventional Radiology in the Diagnosis and Treatment of Pulmonary Arteriovenous Malformations. J Clin Med. 2022;11(21):6282.CrossRefPubMedPubMedCentral
5.
go back to reference White RI Jr, Mitchell SE, Barth KH, et al. Angioarchitecture of pulmonary arteriovenous malformations: an important consideration before embolotherapy. AJR Am J Roentgenol. 1983;140:681–6.CrossRefPubMed White RI Jr, Mitchell SE, Barth KH, et al. Angioarchitecture of pulmonary arteriovenous malformations: an important consideration before embolotherapy. AJR Am J Roentgenol. 1983;140:681–6.CrossRefPubMed
6.
go back to reference Faughnan ME, Palda VA, et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011;48:73–87.CrossRefPubMed Faughnan ME, Palda VA, et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011;48:73–87.CrossRefPubMed
7.
go back to reference BIçakçioğlu P, Gülhan S, Sayilir E, et al. Surgical treatment of pulmonary arteriovenous malformations. Turk J Med Sci. 2017;47:161–6.CrossRefPubMed BIçakçioğlu P, Gülhan S, Sayilir E, et al. Surgical treatment of pulmonary arteriovenous malformations. Turk J Med Sci. 2017;47:161–6.CrossRefPubMed
8.
go back to reference Ando K, Mochizuki A, Kurimoto N, et al. Coil embolization for pulmonary arteriovenous malformation as an organ-sparing therapy: outcome of long-term follow-up. Ann Thorac Cardiovasc Surg. 2011;17:118–23.CrossRefPubMed Ando K, Mochizuki A, Kurimoto N, et al. Coil embolization for pulmonary arteriovenous malformation as an organ-sparing therapy: outcome of long-term follow-up. Ann Thorac Cardiovasc Surg. 2011;17:118–23.CrossRefPubMed
10.
go back to reference Zhang SY, Zhang ZT, Song LO, et al. Fistulectomy as a surgical option for pulmonary arteriovenous malformation. Chin Med J. 2009;122:2321–4.PubMed Zhang SY, Zhang ZT, Song LO, et al. Fistulectomy as a surgical option for pulmonary arteriovenous malformation. Chin Med J. 2009;122:2321–4.PubMed
11.
go back to reference Khanra D, Razi M, Tiwari P, et al. Successful occlusion of a large pulmonary arterio-venous fistula with Amplatzer septal occluder in a 16-year-old cyanotic boy. J Cardiol Cases. 2020;21:242–5.CrossRefPubMedPubMedCentral Khanra D, Razi M, Tiwari P, et al. Successful occlusion of a large pulmonary arterio-venous fistula with Amplatzer septal occluder in a 16-year-old cyanotic boy. J Cardiol Cases. 2020;21:242–5.CrossRefPubMedPubMedCentral
Metadata
Title
A massive pulmonary arteriovenous fistula complicated with coronary atherosclerotic heart disease treated by interventional therapy: a case report
Authors
Jingwen Guo
Hongyong Wang
Mingming Zhang
Publication date
27-06-2024
Publisher
BioMed Central
Published in
Journal of Cardiothoracic Surgery / Issue 1/2024
Electronic ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-024-02866-w

Other articles of this Issue 1/2024

Journal of Cardiothoracic Surgery 1/2024 Go to the issue
Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Medication non-adherence is a major barrier to effective healthcare delivery; half of all patients do not follow their doctor’s recommendations or treatment plan.

Our experts explain the fundamentals with a practical discussion of how to manage non-adherence in two common scenarios: hypertension and asthma control.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine